Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy
Background. Maternal risks of betamethasone have been rarely reported. Case. At 36 weeks’ gestation, a previously healthy 23-year-old gravida with fetal intrauterine growth restriction was admitted to the hospital for steroid administration. Twenty-six hours after the first dose of betamethasone, a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Obstetrics and Gynecology |
| Online Access: | http://dx.doi.org/10.1155/2019/6873057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566786941255680 |
|---|---|
| author | Mojirayo A. Sarumi James W. Hole Robert B. Gherman |
| author_facet | Mojirayo A. Sarumi James W. Hole Robert B. Gherman |
| author_sort | Mojirayo A. Sarumi |
| collection | DOAJ |
| description | Background. Maternal risks of betamethasone have been rarely reported. Case. At 36 weeks’ gestation, a previously healthy 23-year-old gravida with fetal intrauterine growth restriction was admitted to the hospital for steroid administration. Twenty-six hours after the first dose of betamethasone, a maternal bradycardia was initially noted and eventually nadired at 41 beats per minute. Consultation with the cardio-electrophysiology service revealed no other apparent etiologies for the sinus bradycardia. Due to the asymptomatic nature of the maternal bradycardia, pharmacologic interventions were not recommended. With observation alone, a normal maternal heart rate returned by forty-nine hours after the original betamethasone injection. The patient subsequently had an uneventful intrapartum course. Conclusion. Maternal bradycardia can be associated with antenatal betamethasone administration. Due to the transient nature of this side effect, expectant management is recommended as the treatment option for asymptomatic patients. |
| format | Article |
| id | doaj-art-d6286395931b4c87803cf50e568adbc4 |
| institution | Kabale University |
| issn | 2090-6684 2090-6692 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Obstetrics and Gynecology |
| spelling | doaj-art-d6286395931b4c87803cf50e568adbc42025-02-03T01:03:12ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922019-01-01201910.1155/2019/68730576873057Maternal Bradycardia Associated with Betamethasone Administration During PregnancyMojirayo A. Sarumi0James W. Hole1Robert B. Gherman2Division of Maternal-Fetal Medicine, WellSpan Health, York, PA, USADivision of Maternal-Fetal Medicine, WellSpan Health, York, PA, USADivision of Maternal-Fetal Medicine, WellSpan Health, York, PA, USABackground. Maternal risks of betamethasone have been rarely reported. Case. At 36 weeks’ gestation, a previously healthy 23-year-old gravida with fetal intrauterine growth restriction was admitted to the hospital for steroid administration. Twenty-six hours after the first dose of betamethasone, a maternal bradycardia was initially noted and eventually nadired at 41 beats per minute. Consultation with the cardio-electrophysiology service revealed no other apparent etiologies for the sinus bradycardia. Due to the asymptomatic nature of the maternal bradycardia, pharmacologic interventions were not recommended. With observation alone, a normal maternal heart rate returned by forty-nine hours after the original betamethasone injection. The patient subsequently had an uneventful intrapartum course. Conclusion. Maternal bradycardia can be associated with antenatal betamethasone administration. Due to the transient nature of this side effect, expectant management is recommended as the treatment option for asymptomatic patients.http://dx.doi.org/10.1155/2019/6873057 |
| spellingShingle | Mojirayo A. Sarumi James W. Hole Robert B. Gherman Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy Case Reports in Obstetrics and Gynecology |
| title | Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy |
| title_full | Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy |
| title_fullStr | Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy |
| title_full_unstemmed | Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy |
| title_short | Maternal Bradycardia Associated with Betamethasone Administration During Pregnancy |
| title_sort | maternal bradycardia associated with betamethasone administration during pregnancy |
| url | http://dx.doi.org/10.1155/2019/6873057 |
| work_keys_str_mv | AT mojirayoasarumi maternalbradycardiaassociatedwithbetamethasoneadministrationduringpregnancy AT jameswhole maternalbradycardiaassociatedwithbetamethasoneadministrationduringpregnancy AT robertbgherman maternalbradycardiaassociatedwithbetamethasoneadministrationduringpregnancy |